Prostate Cancer
Recent Abstracts
A qualitative study of barriers and facilitators for health behavior change in low-income men with prostate cancer.
January 9, 2024
Benefit of dynamic contrast-enhanced (DCE) imaging for prostate cancer detection depending on readers experience in prostate MRI.
January 9, 2024
The Oncological and Functional Prognostic Value of Unconventional Histology of Prostate Cancer in Localized Disease Treated with Robotic Radical Prostatectomy: An International Multicenter 5-Year Cohort Study.
January 9, 2024
Safety Analyses of the Phase 3 VISION Trial of [177Lu]Lu-PSMA-617 in Patients with Metastatic Castration-resistant Prostate Cancer.
January 9, 2024
Tissue contamination challenges the credibility of machine learning models in real world digital pathology.
January 9, 2024
27-hydroxycholesterol and DNA damage repair: implication in prostate cancer.
January 9, 2024
CDK12 regulates angiogenesis of advanced prostate cancer by IGFBP3.
January 9, 2024
Adverse events and costs among non-metastatic castration-resistant prostate cancer patients.
January 8, 2024
Development and validation of a clinical decision support system based on PSA, microRNAs, and MRI for the detection of prostate cancer.
January 8, 2024
Multiregion sampling of de novo metastatic prostate cancer reveals complex polyclonality and augments clinical genotyping.
January 8, 2024
Patient experiences with tissue-based genomic testing during active surveillance for prostate cancer.
January 8, 2024
Clinical and functional outcomes for risk-appropriate treatments for prostate cancer.
January 8, 2024
Co-designing an online treatment decision aid for men with low-risk prostate cancer: Navigate.
January 8, 2024
High expression of Trop2 is associated with aggressive localized prostate cancer and is a candidate urinary biomarker.
January 8, 2024
Brachytherapy for high grade prostate cancer induces distinct changes in circulating CD4 and CD8 T cells - implications for systemic control.
January 8, 2024
Radiographic Progression-Free Survival and Clinical Progression-Free Survival as Potential Surrogates for Overall Survival in Men With Metastatic Hormone-Sensitive Prostate Cancer.
January 8, 2024
Shared decision-making before prostate cancer screening decisions.
January 5, 2024
Epigenetic disruption of the RARĪ³ complex impairs its function to bookmark AR enhancer interactions required for enzalutamide sensitivity in prostate cancer.
January 5, 2024
Bipolar androgen therapy plus nivolumab for patients with metastatic castration-resistant prostate cancer: the COMBAT phase II trial.
January 5, 2024
Timing of High-Dose Rate Brachytherapy with External Beam Radiotherapy in intermediate and high-risk localised Prostate Cancer (THEPCA): a randomised trial.
January 5, 2024
Page 73 of 1431
Start
Prev
68
69
70
71
72
73
74
75
76
77
Next
End
×
Login
Login to update email address, newsletter preferences and use bookmarks.
Email
Password
Login
Forgot Password?
Sign Up Free